Last Updated 16 May 2022.
4 Vaccines Approved for Use in New Zealand
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 37 countries
15 trials in 12 countries
Approval Source: ir.novavax.com
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 146 countries
78 trials in 26 countries
Approval Source: medsafe.govt.nz
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 111 countries
21 trials in 23 countries
Approval Source: reuters.com
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
63 trials in 30 countries
Approval Source: reuters.com
7 Vaccines in Clinical Trials in New Zealand
-
Jiangsu Rec-Biotechnology Co Ltd
ReCOV- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
5 trials in 1 country
-
SK Bioscience Co Ltd
GBP510- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
6 trials in 6 countries
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 140 countries
63 trials in 30 countries
-
Valneva
VLA2001- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
5 trials in 2 countries
-
Valneva
VLA2101- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 3 trials.
1 trial in 1 country
-
VaxForm
CoV2-OGEN1- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country
-
Yisheng Biopharma
PIKA COVID-19 Vaccine- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 1 trials.
1 trial in 1 country